Sitagliptin/metformin

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC, Population Health Research Institute, Shahid Beheshti University of Medical Sciences

Conditions

ARTInfertilityPolycystic Ovary SyndromeType 2 Diabetes Mellitus

Phase 1

Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients

Shahid Beheshti University of Medical SciencesART, Infertility, Polycystic Ovary Syndrome

Start: 2020-01-10End: 2021-07-30Target: 80Updated: 2021-03-22

Phase 3

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

CompletedNCT02623998

Population Health Research InstituteType 2 Diabetes Mellitus

Start: 2016-07-09End: 2019-11-30Updated: 2022-03-25

Unknown Phase

Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)

CompletedNCT01065766

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2009-03-31End: 2013-05-31Updated: 2015-03-06

Related Papers

Comparing the effect of sitagliptin and metformin on the oocyte and embryo quality in classic PCOS patients undergoing ICSI.

2020-07-287 citations